FDA clearance tops March glaucoma coverage

FDA clearance for an additional Omni surgical system indication and the potential to delay treatment in patients with early glaucoma led glaucoma coverage in March.
Read the recent top glaucoma stories on Healio/OSN below.
Omni receives FDA clearance for additional indication
The FDA has granted 510(k) clearance to the Omni surgical system for canaloplasty followed by trabeculotomy to reduce IOP in primary open-angle glaucoma, according to a press release from Sight Sciences. Read more.
Treatment may be delayed for patients with early glaucoma
If glaucoma is diagnosed early, treatment for the

Full Story →